// App-Quantinova.ai

: Inhibitory Effect of a Novel DNA Aptamer with Artificial Nucleic Bases for Von Willebrand Factor A1 Domain on Platelet Thrombosis Formation

Researchers

Presenter

  • Kazuya Sakai

Principal Investigators

  • Hideo Yagi

  • Masaki Hayakawa

  • Tatsuhiko Someya

  • Kaori Harada

  • Masanori Matsumoto

Medical Centers

  • Department of Blood Transfusion Medicine, Nara Medical University, Kashihara, Nara, Japan

  • TagCyx Biotechnologies Inc., Tokyo, Japan

Locations

  • Japan

Companies

  • N/A

Study Components

Therapeutic Area

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

  • Cardiovascular (CVS)

Disease

  • Acute Coronary Syndromes

  • Venous thrombosis

Biomarkers

  • Translocator protein

  • ZFP36 Ring Finger Protein Like 1

Drug/Treatment

  • Epinephrine

  • Adrenaclick

  • Adenosine

  • Adenosine Intravenous

  • Egaptivon pegol

Outcome

  • N/A

Study Design

  • N/A

Phase

  • II

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved